Rmpl Pharma LLP Rituximab Export Data — India (DGFT 2022–2026)

Name: Rmpl Pharma LLP Rituximab Export Records India — #10 Exporter, 55 Shipments, $92.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rituximab

India Pharmaceutical Trade Intelligence

$19.1M164 Suppliers104 CountriesHS 30021500

ExportsIndia → RUSSIA47.2%India → SRI LANKA11.3%

ImportsGERMANY → India$4.0M SWITZERLAND → India$487.9K

#1 Buyer: JSC R-PHARM

Rmpl Pharma LLP — Rituximab Exporter #10 | $92.7K Trade Value | TransData Nexus | TransData Nexus

Rmpl Pharma LLP — Rituximab Exporter Profile

Indian Pharmaceutical Exporter · #10 for Rituximab · $92.7K export value · DGFT Verified

Rmpl Pharma LLP is the #10 Indian exporter of Rituximab with $92.7K in export value and 55 verified shipments. Rmpl Pharma LLP holds a 0.5% market share in Rituximab exports across 9 countries. The company exports 13 pharmaceutical products worth $438.6K across 3 therapeutic categories.

Rmpl Pharma LLP — Rituximab Export Profile: Buyers & Destinations

Rmpl Pharma LLP Rituximab export treemap — buyers and destination countries | TransData Nexus

Where Does Rmpl Pharma LLP Export Rituximab?

Country	Value	Shipments	Share
LEBANON	$60.7K	22	65.4%
KENYA	$12.9K	9	14.0%
TANZANIA	$6.9K	5	7.5%
TURKEY	$3.8K	7	4.1%
IRAQ	$3.7K	3	4.0%

Who Are the Top Buyers of Rituximab from Rmpl Pharma LLP?

Buyer	Country	Value	Orders
TO THE ORDER OF INVOICE	LEBANON	$62.2K	37
TO THE ORDER OF INVOICE RAISED TO	UGANDA	$25.1K	13
INVOICE RAISED TO	UGANDA	$728	2

Rmpl Pharma LLP supplies Rituximab to 3 buyers globally. The largest buyer is TO THE ORDER OF INVOICE (LEBANON), followed by TO THE ORDER OF INVOICE RAISED TO (UGANDA) and INVOICE RAISED TO (UGANDA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rituximab Formulations Does Rmpl Pharma LLP Export?

Product Description / Formulation	Value	Shipments
MABALL 500MG INJ. (VIAL) (RITUXIMAB 500MG/50ML)	$23.5K	6
RITUXIREL RN 500MG (VIAL)(RITUXIMAB 500MG/5ML) (150 VIALS)VLS	$11.2K	1
MABALL 500MG/50ML INJ.(VIAL) (RITUXIMABINJECTION) (38 VIALS)	$9.4K	3
MABALL 500MG INJ. (VIAL)(RITUXIMAB 500MG/50ML) (75 VIALS)	$5.3K	1
MABALL 500MG 50ML INJ VIAL RITUXIMABINJ 75 VIALS	$5.0K	1
RITUXIREL RN 500MG(VIAL) (RITUXIMAB 500MG/50ML) (50 VIALS)	$3.7K	1
MABALL 500MG INJ. (VIAL) (RITUXIMAB 500MG/50ML) (50 VIALS)	$3.2K	1
MABALL 500MG/50ML INJ.(VIAL) (RITUXIMABINJECTION) (12 VIALS)	$3.0K	3
MABALL 500MG INJ. (37 VIAL) (RITUXIMAB 500MG/50ML)	$2.9K	1
ENFIERA 500MG INJ (VIAL) (RITUXIMAB 500M	$2.8K	4

Rmpl Pharma LLP exports 38 distinct Rituximab formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MABALL 500MG INJ. (VIAL) (RITUXIMAB 500MG/50ML) with 6 shipments worth $23.5K.

How Does Rmpl Pharma LLP Compare to Nearest Rituximab Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	J.A. UNITED EXPORTS PRIVATE LIMITED	$122.3K	20	4	$6.1K
9	R.S. SURGIPHARM PRIVATE LIMITED	$118.2K	63	2	$1.9K
10	RMPL PHARMA LLP ★	$92.7K	55	9	$1.7K
11	PNT PHARMA	$86.7K	12	1	$7.2K
12	SANSKRUTI PHARMA	$71.6K	62	3	$1.2K

Rmpl Pharma LLP ranks #10 among 164 Indian Rituximab exporters. Average shipment value of $1.7K compared to the market average of $57.4K. The closest competitors by value are J.A. UNITED EXPORTS PRIVATE LIMITED and R.S. SURGIPHARM PRIVATE LIMITED.

Which Indian Ports Ship Rituximab Exports?

Port	Shipments	% Share
SAHAR AIR	389	32.0%
SAHAR AIR CARGO ACC (INBOM4)	325	26.7%
Bombay Air	85	7.0%
Bombay Air Cargo	58	4.8%
HYDERABAD ACC (INHYD4)	46	3.8%
DELHI AIR CARGO ACC (INDEL4)	45	3.7%
DELHI AIR	35	2.9%
AHEMDABAD AIR	26	2.1%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rituximab shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Rmpl Pharma LLP matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 55 individual customs records matching Rmpl Pharma LLP exporting Rituximab, covering 38 formulations to 9 countries via 3 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 292+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rituximab

Rituximab

Rmpl Pharma LLP — Rituximab Exporter Profile

Rmpl Pharma LLP — Rituximab Export Profile: Buyers & Destinations

Where Does Rmpl Pharma LLP Export Rituximab?

Who Are the Top Buyers of Rituximab from Rmpl Pharma LLP?

What Is India's Total Rituximab Export Value and How Much Does Rmpl Pharma LLP Contribute?

What Is the Average Shipment Value for Rmpl Pharma LLP's Rituximab Exports?

How Does Rmpl Pharma LLP Compare to Other Indian Rituximab Exporters?

What Rituximab Formulations Does Rmpl Pharma LLP Export?

How Does Rmpl Pharma LLP Compare to Nearest Rituximab Exporters?

Which Indian Ports Ship Rituximab Exports?

What Other Advanced Oncology Products Does Rmpl Pharma LLP Export?

About Rmpl Pharma LLP

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rituximab Export Data from Rmpl Pharma LLP

Rituximab Stats

Company Overview

Top Products by Rmpl Pharma LLP

Related Analysis

Need Detailed Export Data?

Data Source